Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rat Heart
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Sodium-glucose Cotransporter
100%
Mitochondrial Redox State
100%
Substrate Utilization
100%
Ketones
80%
Ketone Oxidation
80%
Fatty Acid Oxidation
60%
Heart Failure
60%
Dapagliflozin
60%
Pyruvate Oxidation
60%
Relative Rate
40%
Cardioprotection
40%
Left Ventricular Ejection Fraction
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
In Vivo Effects
20%
Plasma Glucose
20%
Glucose Uptake
20%
Systemic Metabolism
20%
Mitochondrial Metabolism
20%
Pleiotropic Effects
20%
Gas Chromatography-mass Spectrometry
20%
Differential Impact
20%
Cardiac Metabolism
20%
Cardiac Oxidative Stress
20%
Awake Rat
20%
Fuel Consumption
20%
Heart Metabolism
20%
13C6-glucose
20%
Inhibitor Treatment
20%
Biochemistry, Genetics and Molecular Biology
Cotransporter
100%
Rat
100%
Glucose
100%
Beta Oxidation
75%
Dapagliflozin
75%
Heart Muscle Metabolism
50%
Blood Plasma
50%
Oxidative Stress
25%
Glucose Level
25%
Mass Spectrometry
25%
Mitochondrial Respiration
25%
Glucose Transport
25%
Pleiotropy
25%
Liquid Chromatography-Mass Spectrometry
25%
Tandem Mass Spectrometry
25%
Heart Left Ventricle Ejection Fraction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter
100%
Rat
100%
Ketone
100%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Congestive Heart Failure
37%
Fatty Acid
37%
Dapagliflozin
37%
Pyruvic Acid
37%
Glucose
37%
Chemistry
Sodium
100%
Ketone
100%
Glucose
100%
Pyruvate
42%
Fatty Acids
42%
Dapagliflozin
42%
Mass Spectrometry
14%
Ketones
14%
Tandem Mass Spectrometry
14%
Liquid Chromatography Mass Spectrometry
14%
Oxidative Stress
14%